About the possible mechanisms of calcitriol influence on the development of preeclampsia in pregnant women

  • G. S. Manasova Odessa National Medical University https://orcid.org/0000-0002-1600-5215
  • A. A. Zelinsky Odessa National Medical University
  • N. V. Didenkul Odessa National Medical University
  • N. V. Kuzmin Odessa National Medical University
  • S. V. Derishov Odessa National Medical University
Keywords: preeclampsia; vitamin D; pregnancy; endothelial dysfunction

Abstract

Preeclampsia (PE) of pregnant women remains one of the most important current problems of modern obstetrics. Despite various theories about the pathogenetic mechanisms of its development, new directions in the studying of this problem are continued to emerge. One of the promising areas of researches are works that  devoted to the studying of the vitamin D (VD) role in the genesis of PE, which were appeared due to the discovery of the "non-classical" and "extra-skeletal" effects of calcitriol. It is known now that the regulatory system, which is characterized by vitamin D receptors (VDR), is functioning in at least 38 organs and tissues of the body and controls more than 2200 genes. The VD – VDR system is able to specifically respond to the effects of calcitriol by its participation in angiogenesis, in the immune system and in the most important metabolic processes of the body. The presence of vitamin D receptors directly in the reproductive system and in the placenta allows to redefining of its role in the gestational process, particularly in the development of PE in pregnant women. This direction of research is important not only for understanding some aspects of the pathogenetic mechanisms of PE development, but it`s also the possibility of developing new methods for the prevention and treatment of this complication of pregnancy.

Downloads

Download data is not yet available.

References

1. Akulenko L. V. Rol' polimorfizma genov renin-angiotenzinovoj sistemy v etiologii i patogeneze preeklampsii // Probl. reprodukcii. – 2015. – T. 21, № 1. – P. 8–11.
2. Vasil'eva E. N., Denisova T. G., SHamitova E. N., Assanskij V. G. Obespechennost' vitaminom D pacientok s preeklampsiej // Sovrem. probl. nauki i obrazovaniya. – 2015. – № 3. – http://www.science-education.ru/ru/article/view.id=17323
3. Vasil'eva E. N., Gunin A. G., Denisova T. G. i dr. Osobennosti soderzhaniya receptorov k vitaminu D u pacientok s preeklampsiej // Tam zhe. – 2015. – № 5. – http://www.science-education.ru/ru/article/view.id=21803
4. Ivanov I. I., Cheripko M. V., Kosolapova N. V., Prochan E. N. Preeklampsiya beremennyh: osobennosti patogeneza, taktiki vedeniya // Tavrich. med.-biol. vestn. – 2012. – T. 15, № 2, Ch. 2 (58). – P. 273–286.
5. Manasova G. S. Patogeneticheskie osnovy formirovaniya, razvitiya i lecheniya feto-placentarnoj nedostatochnosti: Avtoref. dis. … kand. med. nauk. – Vinnica, 1999. – 20 p.
6. Medved' V. I., Duda E. M. Preeklampsiya v klinike ekstragenital'noj patologii // Zhurnal «Pochki». – 2013. – 3 (05). – http://www.mif-ua.com/archive/article_print/36619
7. Radzinskij V. E. Sovremennyj vzglyad na patogenez i prognozirovanie gestoza i placentarnoj nedostatochnosti // Vestn. RUDN. Ser. «Medicina. Akusherstvo i ginekologiya». – 2009. – № 5. – P. 162–168.
8. Reznik V. A. Vazoaktivnye faktory v patogeneze preeklampsii // Arterial'naya gipertenziya. – 2006. – № 1. – P. 22–31.
9. Cuhih G. T., Van'ko L. V. Immunnye faktory v etiologii i patogeneze oslozhnenij beremennosti // Akusherstvo i ginekologiya. – 2012. – № 1. – P. 128–136.
10. Trifonova E. A., Spiridonova M. G., Stepanov V. A., Puzyryov V. P. Rol' polimorfnyh variantov nekotoryh genov, uchastvuyushchih v razvitii endotelial'noj disfunkcii, v formirovanii gestoza: obzor // Molekulyarnaya medicina. – 2009. – № 1. – P. 3–9.
11. Hamidullina Z. G. Sovremennyj vzglyad na patogenez preeklampsii // Nauka i zdravoohranenie. – 2010. – № 5. – P. 4–19.
12. Adu-Bonsaffoh K., Antwi D. A., Obed S. A., Gyan B. Nitric oxide dysregulation in the pathogenesis of preeclampsia among Ghanaian women // Integr. Blood Press. Control. – 2015. – N 8. – P. 1–6.
13. Bakacak M., Serin S., Ercan O. et al. Comparison of Vitamin D levels in cases with preeclampsia, eclampsia and healthy pregnant women // Int. J. Clin. Exp. Med. – 2015. – Vol. 9, N 8. – P. 16280–16286.
14. Baker A. M. Haeri S., Camargo C. A. Jr. et al. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia // J. Clin. Endocrinol. Metab. – 2010. – Vol. 95, № 11. – P. 5105-5109.
15. Barrera D., Díaz L., Noyola-Martínez N., Halhali A. Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic Pregnancies // Nutrients. – 2015. – Vol. 7, № 8. – Р. 6465-6490.
16. Bodnar L. M., Catov J. M., Simhan H. N. Maternal vitamin D deficiency increases the risk of preeclampsia // Journal of Clinical Endocrinology and Metabolism. – 2007. – Vol. 92, № 9. – Р. 3517-3522.
17. Brennan L. J., Morton J. S., Davidge S. T. Vascular dysfunction in preeclampsia // Microcirculation. – 2014. – Vol. 21, № 1. – P. 4 – 14.
18. Brosens I. A., Robertson W. B., Dixon H.G. The role of the spiral arteries in thepathogenesis of preeclampsia // Obstetrics & Gynecology Annual. – 1972. – Vol. 1. – P. 177–191.
19. Browne J. L., Klipstein-Grobusch K., Franx A., Grobbee D. E. Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept // Curr. Cardiol. Rep. – 2016. – Vol. 18, N 6. – P. 59 - 70.
20. Cardus A., Panizo S., Encinas M. et al. 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter // Atherosclerosis. – 2004. – Vol. 1. – P. 85–89.
21. Chakhtoura M., Nassar A., Arabi A. et al. Effect of vitamin D replacement on maternal and neonatal outcomes: a randomised controlled trial in pregnant women with hypovitaminosis D. A protocol // BMJ Open. – 2016. – Vol. 6, № 3. – Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785305/
22. Chan S.Y., Susarla S. Y. Vitamin D promotes human extravillous trophoblast invasion in vitro // Placenta. – 2015. – Vol. 36, № 4. – Р. 403-409.
23. DeLuca H.F. Overview of general physiologic features and functions of vitamin D //Am J Clin Nutr December. – 2004. – Vol. 80, № 6. – P. 1689-1696.
24. De-Regil L.M, Palacios C, Lombardo L.K, Peña-Rosas J.P.Vitamin D supplementation for women during pregnancy // Cochrane Database Syst Rev. – 2016. – Vol. 1. – Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747784/
25. Diaz L., Noyola-Martinez N., Barrera D. et al. Calcitriol inhibits TNF-induced inflammatory cytokines in human trophoblasts // J. Reprod. Immunol. – 2009. – Vol. 81. – P. 17–24.
26. Evans K. N., Nguyen L., Chan J. et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human deciduas cells // Biol. Reprod . –2006. – Vol.75, №6. – Р. 816–822.
27. Evans K. N., Bulmer J. N., Kilby M. D., Hewison M. Vitamin D and placental decidual function // J. Soc. Gynecol. Investig. – 2004. – Vol. 11. – P. 263–271.
28. Friedman A. M., Cleary K. L. Prediction and prevention of ischemic placental disease // Semin Perinatol. – 2014. – Vol. 38. – P. 177 - 182.
29. Gupta T., Wahi S., Gupta N., Arora S. et al. Correlation of vitamin D levels in term normotensive and preeclamptic patients in labor // J. Obstet. Gynaecol. India. – 2016. – Vol. 66. – P. 154 - 159.
30. Haugen M., Brantsaeter A. L., Trogstad L. et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women // Epidemiology. – 2009. –Vol.20, № 5. – Р. 720-726.
31. Haussler M. R., Jurutka P. W., Mizwicki M., Norman A. W. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms // Best Pract. Res. Clin. Endocrinol. Metab. – 2011. –Vol. 25. – P. 543 - 559.
32. Hirata M., Serizawa K., Aizawa K., Yogo K. et al. 22-Oxycalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy // Nephrol. Dial. Transplant. – 2013. – Vol. 28. – P. 1166–1174.
33. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on hypertension in pregnancy // Obstet. Gynecol. – 2013. – Vol. 122. – P. 1122 - 1131.
34. La Marca B., Amaral L. M., Harmon A.C. et al. Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia // Jr. Curr. Hypertens. Rep. – 2016. – Vol. 18. – P. 38.
35. Li Y.C., Qiao G.J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure // Steroid Biochem. Mol. Biol. – 2004. – Vol. 89-90 – P. 387-392.
36. Liu N. Q. Vitamin D and regulation of placental inflammation // J. Immunol. – 2011. – Vol. 10, № 186. – P. 5968-5974.
37. Manasova G. S., Zelinsky А. А., Kazarenko O. N.,Globa S. S. VitaminD – deficiency states: some aspects of influence on the course and outcome of pregnancy (review) // Journal of Education, Health and Sport. Formerly Journal of Health Sciences. – 2015. – Vol. 5, № 7. – P. 507 - 520.
38. Meher S., Duley L. Nitric oxide for preventing preeclampsia and its complications. // Cochrane Database Syst. Rev. – 2007. – Vol. 2. – Режим доступа: https://www.ncbi.nlm.nih.gov/pubmed/17443623
39. Molinari C., Uberti F., Grossini E. et al. 1α,25-Dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells // Cell. Physiol. Biochem. – 2011. – Vol. 27. – P. 661–668.
40. Morris H. A., Anderson P. H. Autocrine and paracrine actions of vitamin D // Clin. Biochem. Rev. – 2010. – Vol.31, №4. – P. 129–138.
41. Novakovic B., Sibson M., Ng H.K. et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface // J. Biol. Chem. ― 2009. ― 28. ― P. 14838-14848.
42. Olmos-Ortiz A., Avila E., Durand-Carbajal M., Díaz L. Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes // Nutrients. – 2015. – Vol. 7. – P. 443 - 480.
43. Palmer S. C., McGregor D. O., Macaskill P. et al. Meta-analysis: vitamin D compounds in chronic kidney disease // Ann. Intern. Med. – 2007. – Vol. 147. – P. 840–853.
44. Pérez-López F. R., Pasupuleti V., Mezones-Holguin E. et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials // Fertil. Steril. – 2015. Vol. 103. – P. 1278 - 1288.
45. Prada L.C., Riaño-Medina C. E., Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress // Front. Physiol. – 2014. – Vol. 5. – Art. 372. – Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193194/
46. Queen L. R., Ji Y., Xu B. et al. Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells // J. Physiol. – 2006. – Vol. 576. – P.585–594.
47. Rimpi S., Padma G., Neelam A. Relationship between preeclampsia and vitamin D deficiency: a case control study // Gynec. and Obst. –2015. – Vol. 291, №6. – P. 1247 - 1251.
48. Roberts J.M. Pathophysiology of ischemic placental disease // Semin. Perinatol. – 2014. – Vol. 38. – P. 139 – 145.
49. Robinson C. J. Maternal vitamin D and fetal growth in early-onset severe preeclampsia // Am. J. Obstet. Gynecol. – 2011. – Vol. 6, № 204. – P. 551- 556.
50. Sánchez-Aranguren L. C., Prada C. E., Riaño-Medina. C. E, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress // Front. Physiol. – 2014. – Vol. 5. – Art. 372. – Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193194/
51. Shah D.M. Role of the renin-angiotensin system in the pathogenesis of preeclampsia // Am. J. Physiol. Renal Physiol. – 2005. – Vol. 288. – P. 614-625.
52. Shand A.W., Nassar N., Von Dadelszen P. et al. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for preeclampsia // BJOG: An International Journal of Obstetrics and Gynaecology. – 2010. – Vol.117, № 3. – P.1593-1598.
53. Tannetta D., Sargent I. Placental disease and the maternal syndrome of preeclampsia: missing links? // Curr. Hypertens. Rep. – 2013. Vol. 15. – P. 590 - 599.
54. Tian J., Liu Y., Williams L. A., de Zeeuw D. Potential role of active vitamin D in retarding the progression of chronic kidney disease // Nephrol. Dial. Transplant. – 2007. – Vol. 22. – P. 321–328.
55. Ullah M. I., Koch C. A., Tamanna S. et al. Vitamin D Deficiency and the Risk of Preeclampsia and Eclampsia in Bangladesh // Horm. Metab. Res. – 2013. – Vol. 45, № 09. – P. 682 - 687.
56. Wei S. Q. Vitamin D and pregnancy outcomes // Curr. Opin. Obstet Gynecol. 2014. – Vol. 26. – P. 438 - 447.
57. Zhang L., Zhou Y., Wu Q., Fan W. et al. Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β // Experimental and Therapeutic Medicine. – 2017. – Vol. 22, № 14. – P. 391 - 397.

Abstract views: 115
PDF Downloads: 139
Published
2019-03-26
How to Cite
Manasova, G. S., Zelinsky, A. A., Didenkul, N. V., Kuzmin, N. V., & Derishov, S. V. (2019). About the possible mechanisms of calcitriol influence on the development of preeclampsia in pregnant women. Likars’ka Sprava, (1-2), 53-62. https://doi.org/10.31640/JVD.1-2.2019(8)
Section
Surveys of literature